Education
About Us
Working with TipRanks
Follow Us
IQVIA Holdings Inc (IQV)
NYSE:IQV
IQV Stock Chart & Stats
$217.43
-$0.07(-0.03%)
At close: 4:00 PM EST
$217.43
-$0.07(-0.03%)
Day’s Range― - ―
52-Week Range$134.65 - $225.91
Previous CloseN/A
Volume300.39K
Average Volume (3M)1.48M
Market Cap
$37.08B
Enterprise Value$40.81B
Total Cash (Recent Filing)$2.19B
Total Debt (Recent Filing)$15.70B
Price to Earnings (P/E)29.9
Beta0.92
Next Earnings
Feb 18, 2026EPS Estimate
3.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.00
Shares Outstanding170,000,000
10 Day Avg. Volume1,711,691
30 Day Avg. Volume1,477,068
Financial Highlights & Ratios
PEG Ratio10.65
Price to Book (P/B)5.87
Price to Sales (P/S)2.31
P/FCF Ratio16.85
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue2.60
Enterprise Value/Gross Profit7.59
Enterprise Value/Ebitda12.19
Forecast
1Y Price Target
$219.78Price Target Upside1.08% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
Bulls Say, Bears Say
Bulls Say
Demand EnvironmentAccelerating RFP flow driven by both pharma and biotech is up 20% year-over-year, indicating a robust demand environment.
Net Bookings GrowthIQVIA is experiencing strong net bookings growth, with a 13% year-over-year increase.
Revenue ExpectationsManagement expects revenue growth to be at least the same or better than the 5% increase expected, suggesting confidence in future growth.
Bears Say
Biotech Funding RiskWeak biotech funding poses a risk to CROs, including IQVIA, as it could lead to challenges if the trend continues for an extended period.
Margin DynamicsIQVIA is facing potential headwinds from mix shift and previous willingness to discount work, impacting margin dynamics.
R&D Spending EnvironmentA key risk for IQVIA is a slowdown in the R&D spending environment due to lower end-market pricing or other exogenous factors.
IQVIA Holdings News
IQV FAQ
What was IQVIA Holdings Inc’s price range in the past 12 months?
IQVIA Holdings Inc lowest stock price was $134.65 and its highest was $225.91 in the past 12 months.
What is IQVIA Holdings Inc’s market cap?
IQVIA Holdings Inc’s market cap is $37.08B.
When is IQVIA Holdings Inc’s upcoming earnings report date?
IQVIA Holdings Inc’s upcoming earnings report date is Feb 18, 2026 which is in 112 days.
How were IQVIA Holdings Inc’s earnings last quarter?
IQVIA Holdings Inc released its earnings results on Oct 28, 2025. The company reported $3 earnings per share for the quarter, beating the consensus estimate of $2.982 by $0.018.
Is IQVIA Holdings Inc overvalued?
According to Wall Street analysts IQVIA Holdings Inc’s price is currently Undervalued.
Does IQVIA Holdings Inc pay dividends?
IQVIA Holdings Inc does not currently pay dividends.
What is IQVIA Holdings Inc’s EPS estimate?
IQVIA Holdings Inc’s EPS estimate is 3.4.
How many shares outstanding does IQVIA Holdings Inc have?
IQVIA Holdings Inc has 170,000,000 shares outstanding.
What happened to IQVIA Holdings Inc’s price movement after its last earnings report?
IQVIA Holdings Inc reported an EPS of $3 in its last earnings report, beating expectations of $2.982. Following the earnings report the stock price went up 0.322%.
Which hedge fund is a major shareholder of IQVIA Holdings Inc?
Currently, no hedge funds are holding shares in IQV
IQVIA Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$219.78 (1.08% Upside)
$219.78 (1.08% Upside)
Blogger Sentiment
Bullish
IQV Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 2.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.4%
Last 30 Days ▲ 18.8%
Last 30 Days ▲ 18.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.30%
12-Months-Change
Fundamentals
Return on Equity
19.80%
Trailing 12-Months
Asset Growth
8.46%
Trailing 12-Months
Company Description
IQVIA Holdings Inc
IQVIA Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. The company operates in two primary segments: Technology & Analytics Solutions and Contract Research Services. IQVIA leverages its extensive healthcare data and insights to help clients accelerate drug development, optimize commercial strategies, and improve patient outcomes. Its core offerings include real-world evidence, clinical trial management, regulatory compliance, and market access solutions.
IQV Company Deck
IQV Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call conveyed a generally positive sentiment with strong financial performance, record-high free cash flow, and significant growth in net bookings and backlog. However, there were some challenges, particularly in the R&D Solutions segment and delays in mega trials. The company's focus on AI and technology advancements points to optimism for future efficiencies and growth.View all IQV earnings summariesIQV Revenue Breakdown
55.35% Research & Development Solutions
39.99% Technology & Analytics Solutions
4.66% Contract Sales & Medical Solutions
IQV Stock 12 Month Forecast
Average Price Target
$219.78
▲(1.08% Upside)
Technical Analysis
Ownership Overview
0.89% Insiders
24.98% Mutual Funds
0.41% Other Institutional Investors
48.44% Public Companies and
Individual Investors